FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for brimonidine tartrate submitted by Sandoz Inc, resulting in changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• BRIMONIDINE TARTRATE (brimonidine tartrate)

Snippet

SUPPL AP for BRIMONIDINE TARTRATE (BRIMONIDINE TARTRATE)